The Role of Abnormal Pap Tests in Cervical Cancer Prevention
*Corresponding Author:Received Date: Dec 02, 2024 / Published Date: Dec 30, 2024
Citation: Aleski F (2024) The Role of Abnormal Pap Tests in Cervical Cancer Prevention. Cervical Cancer, 9: 241.DOI: 10.4172/2475-3173.1000241
Copyright: 漏 2024 Aleski F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Cervical cancer is a major public health concern, particularly in low- and middle-income countries where screening programs are less accessible. The Papanicolaou (Pap) test has been instrumental in reducing the incidence and mortality of cervical cancer worldwide. Abnormal Pap test results serve as an early warning system, enabling timely identification and management of precancerous lesions or early-stage cervical cancer. This article explores the role of abnormal Pap tests in cervical cancer prevention, examining their significance in screening programs, the factors influencing test results, and their impact on treatment and prognosis. The discussion underscores the necessity of public health strategies to improve access to and understanding of cervical screening programs globally.
